STOCKWATCH
·
Pharmaceuticals
Press Release11 May 2024, 07:25 pm

Ami Organics Ltd Surpasses Rs. 200 Crore Revenue Mark for the First Time in Q4 FY24

AI Summary

Ami Organics Limited reported financial results for Q4 and FY24 ending March 31, 2024, announcing a revenue from operations of Rs. 225 crore, a 20.7% Year-over-Year (YoY) increase and a 35.2% sequential growth. The advanced pharmaceuticals business grew by 18% YoY and 47% QoQ, and the specialty chemicals business grew by 36% YoY. Ami Organics received the 'Gold Medal' accreditation from EcoVadis and was granted three process patents from The Patent Office, India.

Key Highlights

  • Revenue from operations surpassed Rs. 200 crore mark for the first time, reaching Rs. 225 crore in Q4 FY24
  • Advanced pharmaceuticals business grew by 18% YoY and 47% QoQ
  • Specialty chemicals business grew by 36% YoY
  • Received 'Gold Medal' accreditation from EcoVadis
  • Granted three process patents from The Patent Office, India
AMIORG
Pharmaceuticals
Ami Organics Ltd

Price Impact